store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 59,000 |
5 mg | 在庫あり | ¥ 144,500 |
10 mg | 在庫あり | ¥ 226,500 |
25 mg | 在庫あり | ¥ 454,500 |
50 mg | 在庫あり | ¥ 725,500 |
100 mg | 在庫あり | ¥ 1,184,500 |
説明 | Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults. |
In vitro | Orforglipron potently stimulates GLP-1R-induced cAMP accumulation with partial agonist activity and no detectable recruitment of GLP-1R-mediated β-arrestin was observed[2]. |
別名 | LY3502970, GLP-1 receptor agonist 1 |
分子量 | 882.96 |
分子式 | C48H48F2N10O5 |
CAS No. | 2212020-52-3 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 44.15 mg/mL (50 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Orforglipron 2212020-52-3 GPCR/G Protein Glucagon Receptor LY-3502970 LY3502970 LY 3502970 GLP-1 receptor agonist 1 Inhibitor inhibitor inhibit